The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations

28 September 2009 | Gert Van Assche, Axel Dignass, Walter Reinisch, C. Janneke van der Woude, Andreas Sturm, Martine De Vos, Mario Guslandi, Bas Oldenburg, Iris Dotan, Philippe Marteau, Alessandro Ardizzone, Daniel C. Baumgart, Geert D'Haens, Paolo Gionchetti, Francisco Portela, Boris Vucelic, Johan Söderholm, Johanna Escher, Sibylle Koletzko, Kaija-Leena Kolho, Milan Lukas, Christian Mottet, Herbert Tilg, Séverine Vermeire, Frank Carbonnel, Andrew Cole, Gottfried Novacek, Max Reinshagen, Epameinondas Tsianos, Klaus Herrlinger, Bas Oldenburg, Yoram Bouhnik, Ralf Kiesslich, Eduard Stange, Simon Travis, James Lindsay for the European Crohn's and Colitis Organisation (ECCO)
This section of the article focuses on the diagnosis and management of special situations in Crohn's disease (CD), including post-operative recurrence, fistulating CD, CD in children and adolescents, and pregnancy. Key points include: 1. **Post-Operative Recurrence**: - Post-operative recurrence rates are high, with endoscopic follow-up showing recurrence rates of 65-90% within 12 months and 80-100% within 3 years. - Thiopurines are more effective than mesalazine or antibiotics alone in preventing recurrence. - Ileocolonoscopy is recommended within the first year after surgery for diagnosis and treatment decisions. 2. **Fistulating CD**: - Fistulating CD includes perianal and non-perianal fistulae. - Perianal fistulae are the most common type, with a prevalence of up to 54% in CD patients. - Diagnosis involves pelvic MRI, examination under anesthesia, and anorectal ultrasound. - Treatment options include antibiotics, thiopurines, anti-TNF agents, and surgical procedures. - Seton placement is recommended for complex fistulae, and active luminal CD should be treated concurrently with surgical management. 3. **CD in Children and Adolescents**: - Incidence is approximately 3 per 100,000, with a rise in Europe over the past decade. - Diagnosis involves thorough history, examination, and imaging. - Exclusive enteral nutrition (EEN) and corticosteroids are effective for induction of remission. - Multidisciplinary teams are recommended for care. 4. **Pregnancy**: - Fertility is affected by disease activity, and pregnancy can influence CD course. - Medical treatments such as aminosalicylates, antibiotics, corticosteroids, and anti-TNF agents are used during pregnancy. - Breastfeeding support is also discussed. The article provides detailed guidelines and recommendations for managing these special situations, emphasizing the importance of individualized treatment plans based on patient-specific factors.This section of the article focuses on the diagnosis and management of special situations in Crohn's disease (CD), including post-operative recurrence, fistulating CD, CD in children and adolescents, and pregnancy. Key points include: 1. **Post-Operative Recurrence**: - Post-operative recurrence rates are high, with endoscopic follow-up showing recurrence rates of 65-90% within 12 months and 80-100% within 3 years. - Thiopurines are more effective than mesalazine or antibiotics alone in preventing recurrence. - Ileocolonoscopy is recommended within the first year after surgery for diagnosis and treatment decisions. 2. **Fistulating CD**: - Fistulating CD includes perianal and non-perianal fistulae. - Perianal fistulae are the most common type, with a prevalence of up to 54% in CD patients. - Diagnosis involves pelvic MRI, examination under anesthesia, and anorectal ultrasound. - Treatment options include antibiotics, thiopurines, anti-TNF agents, and surgical procedures. - Seton placement is recommended for complex fistulae, and active luminal CD should be treated concurrently with surgical management. 3. **CD in Children and Adolescents**: - Incidence is approximately 3 per 100,000, with a rise in Europe over the past decade. - Diagnosis involves thorough history, examination, and imaging. - Exclusive enteral nutrition (EEN) and corticosteroids are effective for induction of remission. - Multidisciplinary teams are recommended for care. 4. **Pregnancy**: - Fertility is affected by disease activity, and pregnancy can influence CD course. - Medical treatments such as aminosalicylates, antibiotics, corticosteroids, and anti-TNF agents are used during pregnancy. - Breastfeeding support is also discussed. The article provides detailed guidelines and recommendations for managing these special situations, emphasizing the importance of individualized treatment plans based on patient-specific factors.
Reach us at info@study.space